Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U51909DL2014PTC264328 Incorporated 01 February 2014 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹18.04 Lakh
▼ 0.35% YoY
Net profit · FY 2025
₹1.66 Lakh
Net margin 9.2%
EBITDA · FY 2025
₹2.26 Lakh
EBITDA margin 12.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Synthokind Pharmaceuticals Private Limited

Data last updated:

Synthokind Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 February 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2014PTC264328. Its GSTIN is 07AAUCS3857N1ZC (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veena Mittal and Amit Mittal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042.

As per the financials filed for FY 2025, the company reported a revenue of ₹18.04 Lakh. For the same year it recorded a net profit of ₹1.66 Lakh (net margin 9.2%) and EBITDA of ₹2.26 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 19% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U51909DL2014PTC264328
Registration Number 264328
Incorporation Date 01 February 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Synthokind Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Synthokind Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Synthokind Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Synthokind Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Synthokind Pharmaceuticals Private Limited, buy the company report.

Financials of Synthokind Pharmaceuticals Private Limited

FY 2025 filings available

Synthokind Pharmaceuticals Private Limited reported revenue of ₹18.04 Lakh for FY 2025.

Revenue · FY 2025
₹18.04 Lakh
Net profit · FY 2025
₹1.66 Lakh margin 9.2%
EBITDA · FY 2025
₹2.26 Lakh margin 12.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 10%
5 years · compounded
▲ 58%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.26 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.66 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin12.5%
Net Profit Margin9.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Synthokind Pharmaceuticals Private Limited, buy the company report.

Board of directors of Synthokind Pharmaceuticals Private Limited

Synthokind Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Veena MittalDirector12 Jan 20179 Years 10 MonthsCurrent
Amit MittalAdditional Director26 Mar 20188 Years 7 MonthsCurrent

Peer comparison

Synthokind Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Habeeba Pharmaceuticals Private Limited₹18.08 Lakh (FY 2021)170.0%Pune, Maharashtra, India
Synthokind Pharmaceuticals Private Limitedthis company₹18.04 Lakh (FY 2025)₹1.66 Lakh9.2%Delhi, India
Recure Healthcare Private Limited₹18.04 Lakh (FY 2025)4.0%Rajkot, Gujarat, India
Brunson Healthcare Private Limited₹18.02 Lakh (FY 2018)64.0%Kalyan West, Maharashtra, India

To see the full peer comparison of Synthokind Pharmaceuticals Private Limited, buy the company report.

Auditor

Synthokind Pharmaceuticals Private Limited is audited by ANKIT SK JAIN & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ANKIT SK JAIN & CO.FY 2023032983N

Shareholding

The shareholding of Synthokind Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Synthokind Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Synthokind Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Synthokind Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AAUCS3857N1ZCDelhiActive28 Apr 2019

To see the full GST registrations and return filing status of Synthokind Pharmaceuticals Private Limited, buy the company report.

Recent activity

Synthokind Pharmaceuticals Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Vishav Deep Bansal ceased to be Director on 09 Jul 2018.

AGM
Synthokind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Synthokind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Vishav Deep Bansal ceased to be Director.
Appointed
Amit Mittal was appointed as Additional Director.
Ceased
Veena Mittal ceased to be Additional Director.
Ceased
Surender Kumar ceased to be Director.
Appointed
Veena Mittal was appointed as Director.
Ceased
Amardeep Bansal ceased to be Director.
Incorporation
01 Feb 2014
Synthokind Pharmaceuticals Private Limited was registered on 01 Feb 2014 with Roc Delhi & aged 12 years 9 months as per MCA records.

Frequently asked questions

Synthokind Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 February 2014 (12+ years old) and is registered under CIN U51909DL2014PTC264328.

Synthokind Pharmaceuticals has 2 current directors:

The latest financial statements of Synthokind Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Synthokind Pharmaceuticals is 07AAUCS3857N1ZC, registered in Delhi.

The CIN (Corporate Identification Number) of Synthokind Pharmaceuticals is U51909DL2014PTC264328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Synthokind Pharmaceuticals was incorporated on 01 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Synthokind Pharmaceuticals by revenue are Habeeba Pharmaceuticals Private Limited, Recure Healthcare Private Limited, Brunson Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Vishav Deep Bansal ceased to be Director on 09 Jul 2018. Amit Mittal was appointed as Additional Director on 26 Mar 2018. Veena Mittal ceased to be Additional Director on 30 Sep 2017. Synthokind Pharmaceuticals has 6 board changes on record in total.

The registered office of Synthokind Pharmaceuticals is at House No.488 02nd Floor Near Rana Public School Shahbad Daulatp, Ur, Delhi, India – 110042.

Synthokind Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Synthokind Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.